Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Indaptus Therapeutics Inc...

    NASDAQ: INDP · Real-Time Price · USD
    0.35
    0.01 (1.95%)
    At close: Jun 09, 2025, 3:59 PM

    Indaptus Therapeutics Statistics

    Share Statistics

    Indaptus Therapeutics has 16.03M shares outstanding. The number of shares has increased by 68.98% in one year.

    Shares Outstanding

    n/a
    		 16.03M

    Shares Change (YoY)

    n/a
    		 68.98%

    Shares Change (QoQ)

    n/a
    		 20.1%

    Owned by Institutions (%)

    n/a
    		 6.71%

    Shares Floating

    n/a
    		 12.9M

    Failed to Deliver (FTD) Shares

    n/a
    		 71

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    The latest short interest is 81.07K, so 0.51% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 81.07K

    Short % of Shares Out

    n/a
    		 0.51%

    Short % of Float

    n/a
    		 0.71%

    Short Ratio (days to cover)

    n/a
    		 1.51

    Valuation Ratios

    The PE ratio is -0.52 and the forward PE ratio is -0.37. Indaptus Therapeutics's PEG ratio is 0.04.

    PE Ratio

    n/a
    		 -0.52

    Forward PE

    n/a
    		 -0.37

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0

    PB Ratio

    n/a
    		 2

    P/FCF Ratio

    n/a
    		 -0.64

    PEG Ratio

    n/a
    		 0.04
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Indaptus Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.95, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 1.95

    Quick Ratio

    n/a
    		 1.95

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-2,146,003.86

    Employee Count

    n/a
    		 7

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -86.79% in the last 52 weeks. The beta is 1.12, so Indaptus Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.12

    52-Week Price Change

    n/a
    		 -86.79%

    50-Day Moving Average

    n/a
    		 0.44

    200-Day Moving Average

    n/a
    		 0.92

    Relative Strength Index (RSI)

    n/a
    		 39.35

    Average Volume (20 Days)

    n/a
    		 647,398

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -15.37M

    Net Income

    n/a
    		 -15.02M

    EBITDA

    n/a
    		 -15.02M

    EBIT

    n/a
    		 -15.02M

    Earnings Per Share (EPS)

    n/a
    		 -1.61
    Full Income Statement

    Balance Sheet

    The company has 5.79M in cash and 84.16K in debt, giving a net cash position of 5.7M.

    Cash & Cash Equivalents

    n/a
    		 5.79M

    Total Debt

    n/a
    		 84.16K

    Net Cash

    n/a
    		 5.7M

    Retained Earnings

    n/a
    		 -60.44M

    Total Assets

    n/a
    		 5.41M

    Working Capital

    n/a
    		 2.35M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -12.32M and capital expenditures 0, giving a free cash flow of -12.32M.

    Operating Cash Flow

    n/a
    		 -12.32M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -12.32M

    FCF Per Share

    n/a
    		 -1.32
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    INDP does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for INDP is $8.5, which is 2328.6% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $8.5

    Price Target Difference

    n/a
    		 2328.6%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jul 27, 2021. It was a backward split with a ratio of 1:4.

    Last Split Date

    n/a
    		 Jul 27, 2021

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:4

    Scores

    Altman Z-Score

    n/a
    		 -24.8

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist